Pshezhetsky A V, Potier M
Service de Génétique Médicale, Hôpital Sainte-Justine, Montréal, Québec, Canada H3T 1C5.
J Biol Chem. 1996 Nov 8;271(45):28359-65. doi: 10.1074/jbc.271.45.28359.
N-Acetylgalactosamine-6-sulfate sulfatase (GALNS) catalyzes the first step of intralysosomal keratan sulfate (KS) catabolism. In Morquio type A syndrome GALNS deficiency causes the accumulation of KS in tissues and results in generalized skeletal dysplasia in affected patients. We show that in normal cells GALNS is in a 1.27-MDa complex with three other lysosomal hydrolases: beta-galactosidase, alpha-neuraminidase, and cathepsin A (protective protein). GALNS copurifies with the complex by different chromatography techniques: affinity chromatography on both cathepsin A-binding and beta-galactosidase-binding columns, gel filtration, and chromatofocusing. Anti-human cathepsin A rabbit antiserum coprecipitates GALNS together with cathepsin A, beta-galactosidase, and alpha-neuraminidase in both a purified preparation of the 1. 27-MDa complex and crude glycoprotein fraction from human placenta extract. Gel filtration analysis of fibroblast extracts of patients deficient in either beta-galactosidase (beta-galactosidosis) or cathepsin A (galactosialidosis), which accumulate KS, demonstrates that the 1.27-MDa complex is disrupted and that GALNS is present only in free homodimeric form. The GALNS activity and cross-reacting material are reduced in the fibroblasts of patients affected with galactosialidosis, indicating that the complex with cathepsin A may protect GALNS in the lysosome. We suggest that the 1.27-MDa complex of lysosomal hydrolases is essential for KS catabolism and that the disruption of this complex may be responsible for the KS accumulation in beta-galactosidosis and galactosialidosis patients.
N-乙酰半乳糖胺-6-硫酸酯酶(GALNS)催化溶酶体内硫酸角质素(KS)分解代谢的第一步。在A型黏多糖贮积症中,GALNS缺乏会导致KS在组织中蓄积,并在受影响的患者中引起全身性骨骼发育异常。我们发现,在正常细胞中,GALNS与其他三种溶酶体水解酶形成1.27兆道尔顿的复合物:β-半乳糖苷酶、α-神经氨酸酶和组织蛋白酶A(保护蛋白)。GALNS通过不同的色谱技术与该复合物共纯化:在组织蛋白酶A结合柱和β-半乳糖苷酶结合柱上进行亲和色谱、凝胶过滤和聚焦色谱。抗人组织蛋白酶A兔抗血清在1.27兆道尔顿复合物的纯化制剂和人胎盘提取物的粗糖蛋白组分中,将GALNS与组织蛋白酶A、β-半乳糖苷酶和α-神经氨酸酶一起共沉淀。对积累KS的β-半乳糖苷酶缺乏症(β-半乳糖苷沉积症)或组织蛋白酶A缺乏症(半乳糖唾液酸沉积症)患者的成纤维细胞提取物进行凝胶过滤分析表明,1.27兆道尔顿的复合物被破坏,并且GALNS仅以游离同二聚体形式存在。在半乳糖唾液酸沉积症患者的成纤维细胞中,GALNS活性和交叉反应物质减少,这表明与组织蛋白酶A形成的复合物可能在溶酶体中保护GALNS。我们认为,溶酶体水解酶的1.27兆道尔顿复合物对KS分解代谢至关重要,并且该复合物的破坏可能是β-半乳糖苷沉积症和半乳糖唾液酸沉积症患者中KS蓄积的原因。